Sources sought
YELLOW FEVER VACCINE
SPE2DP24Q0084
Defense Logistics Agency, DLA Troop Support. Pharmaceutical Preparation Manufacturing.
Response deadline
March 18, 2024 at 5:00 AM EDT
Closed 959 days ago. Posted March 14, 2024. Scheduled to archive April 2, 2024.
Get the next one like this from Defense Logistics Agency by email, the day it is posted.Find my opportunities
This one closed in 2024
9 like it are open now in pharmaceutical preparation manufacturing
- Sacubitril/Valsartan Tablets (VA-27-00014055)
Department of Veterans Affairs, Nac Pharmaceuticals
PresolicitationNAICS 325412Anywhere in the US36E79727R0007Closes tomorrowNov 3 - Methylphenidate ER
Defense Logistics Agency, DLA Troop Support
SolicitationNAICS 325412Anywhere in the USSPE2D226R0013Closes in 4 daysNov 6 - FY27 Lenalidomide BPA
Department of Veterans Affairs, 262-Network Contract Office 22
Sources soughtNAICS 325412Anywhere in the US36C26227Q0083Closes in 10 daysNov 12
Description
As published on SAM.gov.
The Defense Logistics Agency- Troop Support is seeking sources capable of providing YELLOW FEVER VACCINE, USP, One Vial (Sufficient for 5 Doses). CONTAINS 3ML.
UNIT OF ISSUE: "EACH" (1 VIAL). REQ REFRIG. BTWN 2-8 DEG. C; SUBJECT TO DAMAGE BY FREEZING. Shelf life is 12 months. At least 10 months of shelf life shall remain at the time of delivery to the first government activity. DLA Troop Support has a requirement for Yellow Fever Vaccine of 47 Vials. The vaccine shall be delivered to the Defense Distribution Depot Norfolk, VA, and the desirable delivery time is end of March 2024. This is a request for information (RFI) and does not commit the U.S. Government to issue a solicitation, make an award, or pay any costs associated with responding to the RFI. All submitted information shall remain with the U.S. Government and will not be returned.
Currently Marketed YELLOW FEVER VACCINE
If your firm currently markets YELLOW FEVER VACCINE, please provide information with respects to the following:
1.Place of Manufacture 2.FDA registration information 3.Product Name and description including description of any special features 4.Current unit sale price 5.Delivery days for this item and earliest product available time
New Products Under Development
For products under development, describe the current stage of development and whether the product has undergone independent laboratory testing or FDA testing/trials etc. Firms and organizations that currently develop or manufacture product described in this RFI or that have technologies, pharmaceuticals, or manufacturing capabilities under development are invited to submit information to DLA Troop Support.
Data obtained from this Request For Information (RFI) will be used by DLA Troop Support in making recommendations and decisions on the development of an appropriate planning and procurement strategy for Yellow Fever Vaccine.
All information submitted will be kept confidential as allowed by relevant Federal law and will be eligible for additional special protections under the conditions of the Protected Critical Infrastructure Information (PCII) Program outlined in the Critical Infrastructure Information Act of 2002. Your response to this RFI may be submitted electronically in pdf format and emailed to the Contracting Officer shairy.cartagena@dla.mil.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
March 14, 2024
Sources sought
Due March 18, 2024 at 5:00 AM EDT. SAM.gov, notice b33fd3f20f3d459b80f9f7f632cbaed0
Points of contact
- Shairy M. Cartagena215-737-0730Shairy.Cartagena@dla.mil215.737.0730